The
albuterol component of
DuoNeb belongs to a class of drugs called beta-adrenergic receptor agonists, or beta agonists for short. Beta agonists stimulate beta receptors in the body, including those on the muscles around the airways. This stimulation causes the muscles to relax, which opens up the airways and allows more air to get into and through the lungs.
The other component of DuoNeb (
ipratropium) belongs to a group of medications known as anticholinergics or antimuscarinics. By binding to specific receptors in the airway, called muscarinic receptors, ipratropium helps the smooth muscle of the airway to relax.
DuoNeb is not approved for use in people under the age of 18. Be sure to talk to your healthcare provider about using the medication in children.
On occasion, your healthcare provider may recommend DuoNeb for treating something other than
COPD. Using the medication to treat
asthma is considered an
off-label use.
Previous
Add this article to your Favorites
Email this article
Print